Horizon Pharma, Inc. (NASDAQ:HZNP)

What’s Next for Horizon Pharma After This Late-Stage TED Trial

Horizon Pharma PLC (NASDAQ: HZNP) has announced results from its late-stage confirmatory trial evaluating teprotumumab for the treatment of active thyroid eye disease (TED), and that sent shares soaring on ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Altice, Blue Apron, CubeSmart, Horizon Pharma, KB Home, Las Vegas Sands, Mylan, Switch and More

The futures once again looked lower Thursday morning as investors remain concerned about bellwether tech stocks breaking down and oil entering into a bear market. Many market pundits remain bullish ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Applied Materials, Barrick Gold, Comcast, GoDaddy, Intel, PG&E, Qualcomm, Sirius XM and More

Stocks were indicated to open lower by a tiny margin on Monday, after the indications were for a positive open earlier in the morning. Investors have had less success buying ...
Read Full Story »

10 Top Irish Stocks Worth Keeping an Eye On

If the St. Patrick’s Day observances have investors pondering opportunities in the Emerald Isle, there are a few things to know. First, Ireland has been known for some time for ...
Read Full Story »

5 Top Jefferies Health Care Picks Have Big-Time Potential

Health care spending in the United States is huge, and it continues to grow at a rapid pace as the population is aging, and the aging population is living longer. ...
Read Full Story »

Stifel Has 5 Specialty Pharmaceutical 2018 Buys With Massive Upside Potential

Despite a roaring market in 2017, in which the S&P 500 was up almost 20% on the year, the specialty pharmaceutical group and biotechs severely underperformed. In addition, the performance ...
Read Full Story »

Top Analyst Upgrades and Downgrades: ADM, BlackRock, DexCom, Mallinckrodt, McDonald’s, Philip Morris, Redfin and More

Stocks were indicated to open lower on Thursday, but the indexes remains very close to all-time highs. The trend that has prevailed during this eight-year bull market is that investors ...
Read Full Story »

Horizon Pharma Wins Big in Q2

Horizon Pharma PLC (NASDAQ: HZNP) released its most recent quarterly earnings report before the markets opened on Monday. The firm said that it had $0.41 in earnings per share (EPS) ...
Read Full Story »

4 Biotech and Specialty Pharma Stocks With 80% to 200% Upside Potential

Needless to say, the biotech world has had a very difficult 18 months. Even the biggest and the best companies, many of which trade cheaper than big pharmaceutical companies, have suffered ...
Read Full Story »

Pandora, Hertz Plunge into Tuesday’s 52-Week Low Club

May 9, 2017: Here are four stocks trading with relatively heavy volume among 83 equities making new 52-week lows in Tuesday's session. On the NYSE, decliners led advancers by about ...
Read Full Story »

Horizon Pharma, TherapeuticsMD Dive into Monday’s 52-Week Low Club

May 8, 2017: Here are four stocks trading with relatively heavy volume among 93 equities making new 52-week lows in Monday's session. On the NYSE, decliners led advancers by about ...
Read Full Story »

Horizon Pharma Sinks on Missed Earnings and Guidance

Horizon Pharma PLC (NASDAQ: HZNP) saw its shares hit a 52-week low on Monday after the company released its first-quarter financial results. The company said that it had $0.21 in ...
Read Full Story »
hammered

7 Companies That Destroyed Shareholders Last Week

The S&P 500 and Dow are pushing new highs as 2016 comes to a close in the wake of the U.S. presidential election. Although this tailwind has been incredibly strong, ...
Read Full Story »
tired frustrated unhappy business person

Horizon Pharma Falls on Late-Stage Miss and Discontinuation

Horizon Pharma PLC (NASDAQ: HZNP) saw its shares take a big step back on Thursday after the company reported topline results from one of its late-stage trials. Specifically, the company ...
Read Full Story »
Female patient on gurney

Horizon Pharma Impresses With Q3 Earnings

Horizon Pharma PLC (NASDAQ: HZNP) reported its third-quarter financial results on Monday before the markets opened. The company said that it had $0.70 in earnings per share (EPS) and $208.7 ...
Read Full Story »